1、17. Diabetes Advocacy:Standardsof Medical Care in Diabetes2022Diabetes Care 2022;45(Suppl. 1):S254S255 | https:/doi.org/10.2337/dc22-S017American Diabetes AssociationProfessional Practice Committee*The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes”includes ADAs current c
2、linical practice recommendations and is intended to providethe components of diabetes care, general treatment goals and guidelines, and toolsto evaluate quality of care. Members of the ADA Professional Practice Committee, amultidisciplinaryexpertcommittee(https:/doi.org/10.2337/dc22-SPPC),arerespon-
3、sible for updating the Standards of Care annually, or more frequently as warranted.For a detailed description of ADA standards, statements, and reports, as well as theevidence-grading system for ADAs clinical practice recommendations, pleaserefer to the Standards of Care Introduction (https:/doi.org
4、/10.2337/dc22-SINT).Readers who wish to comment on the Standards of Care are invited to do so atprofessional.diabetes.org/SOC.Managing the daily health demands of diabetes can be challenging. People livingwith diabetes should not have to face discrimination due to diabetes. By advocat-ing for the ri
5、ghts of those with diabetes at all levels, the American Diabetes Associ-ation (ADA) can help to ensure that they live a healthy and productive life. Astrategic goal of the ADA is for more children and adults with diabetes to live freefrom the burden of discrimination. The ADA is also focused on maki
6、ng sure cost isnot a barrier to successful diabetes management.One tactic for achieving these goals has been to implement the ADA Standards ofCare through advocacy-oriented position statements. The ADA publishes evidence-based, peer-reviewed statements on topics such as diabetes and employment, diab
7、e-tes and driving, insulin access and affordability, and diabetes management in certainsettings such as schools, childcare programs, and correctional institutions. In additionto the ADAs clinical documents, these advocacy statements are important tools ineducating schools, employers, licensing agenc
8、ies, policy makers, and others aboutthe intersection of diabetes medicine and the law and for providing scientifically sup-ported policy recommendations.ADVOCACY STATEMENTSThe following is a partial list of advocacy statements ordered by publication date,with the most recent statement appearing firs
9、t.Insulin Access and AffordabilityThe ADAs Insulin Access and Affordability Working Group compiled public informationand convened a series of meetings with stakeholders throughout the insulin supplychain to learn how each entity affects the cost of insulin for the consumer.Their conclu-sions and rec
10、ommendations are published in the following ADA statement: Cefalu WT,Dawes DE, Gavlak G, et al.; Insulin Access and Affordability Working Group. InsulinAccess and Affordability Working Group: conclusions and recommendations. Diabetes*A complete list of members of the AmericanDiabetesAssociationProfe
11、ssionalPracticeCommittee can be found at https:/doi.org/10.2337/dc22-SPPC.Suggested citation: American Diabetes Asso-ciationProfessionalPracticeCommittee.17.Diabetes advocacy: Standards of Medical Care inDiabetes2022. Diabetes Care 2022;45(Suppl.1):S254S255 2021 by the American Diabetes Association.
12、Readers may use this article as long as thework is properly cited, the use is educationaland not for profit, and the work is not altered.Moreinformationisavailableathttps:/diabetesjournals.org/journals/pages/license.17. DIABETES ADVOCACYS254Diabetes Care Volume 45, Supplement 1, January 2022Download
13、ed from http:/diabetesjournals.org/care/article-pdf/45/Supplement_1/S254/636867/dc22s017.pdf by guest on 10 July 2022Care 2018;41:12991311 published cor-rectionappearsinDiabetesCare2018;41:1831;https:/doi.org/10.2337/dci18-0019 (first publication 2018).Diabetes Care in the School SettingA sizable po
14、rtion of a childs day is spentin school, so close communication withand cooperation of school personnel areessential to optimize diabetes manage-ment, safety, and academic opportunities.See the following ADA position statementfor diabetes management information forstudents with diabetes in the eleme
15、ntaryand secondary school settings.Jackson CC, Albanese-ONeill A, ButlerKL, et al.; American Diabetes Association.Diabetes care in the school setting: aposition statement of the American Dia-betes Association. Diabetes Care 2015;38:19581963;https:/doi.org/10.2337/dc15-1418 (first publication 1998; l
16、atestrevision 2015).Care of Young Children WithDiabetes in the Childcare SettingVery young children (aged6 years)with diabetes have legal protectionsand can be safely cared for by childcareproviderswithappropriatetraining,access to resources, and a system ofcommunication with parents and thechilds d
17、iabetes provider. See the follow-ing ADA position statement for informa-tion on young children aged 6 years insettings such as day care centers, pre-schools, camps, and other programs.SiminerioLM,Albanese-ONeillA,Chiang JL, et al.; American Diabetes Asso-ciation. Care of young children with dia-bete
18、s in the childcare setting: a positionstatementoftheAmericanDiabetesAssociation. Diabetes Care 2014;37:28342842; https:/doi.org/10.2337/dc14-1676(first publication 2014).Diabetes and DrivingPeople with diabetes who wish to oper-ate motor vehicles are subject to agreat variety of licensing requiremen
19、tsapplied by both state and federal juris-dictions. For an overview of existinglicensing rules for people with diabetes,factors that impact driving for thispopulation, and general guidelines forassessing driver fitness and determiningappropriate licensing restrictions, seethe following ADA position
20、statement.Editorsnote:Federalcommercialdriving rules for individuals with insulin-treated diabetes changed on 19 Novem-ber 2018. These changes will be reflectedin a future updated ADA statement.Lorber D, Anderson J, Arent S, et al.;American Diabetes Association. Diabetesand driving. Diabetes Care 20
21、14;37(Suppl.1):S97S103;https:/doi.org/10.2337/dc14-S097 (first publication 2012).Diabetes and EmploymentAny person with diabetes, whether insu-lin treated or noninsulin treated, shouldbe eligible for any employment for whichhe or she is otherwise qualified. Employ-ment decisions should never be base
22、don generalizations or stereotypes regard-ing the effects of diabetes. For a generalset of guidelines for evaluating individualswith diabetes for employment, includinghow an assessment should be performedand what changes (accommodations) inthe workplace may be needed for anindividual with diabetes,
23、see the follow-ing ADA position statement.Anderson JE, Greene MA, Griffin JW Jr,et al.; American Diabetes Association.Diabetes and employment. Diabetes Care2014;37(Suppl. 1):S112S117; https:/doi.org/10.2337/dc14-S112 (first publication1984; latest revision 2009).Diabetes Care in CorrectionalInstitut
24、ionsPeople with diabetes in correctionalfacilities should receive care that meetsnational standards. Correctional institu-tions should have written policies andprocedures for the management of dia-betes and for the training of medicaland correctional staff in diabetes carepractices. For a general se
25、t of guidelinesfor diabetes care in correction institu-tions, see the following ADA positionstatement.American Diabetes Association. Dia-betes management in correctional insti-tutions.DiabetesCare2014;37(Suppl. 1):S104S111; https:/doi.org/10.2337/dc14-S104(firstpublication1989; latest revision 2008).care.diabetesjournals.orgDiabetes AdvocacyS255Downloaded from http:/diabetesjournals.org/care/article-pdf/45/Supplement_1/S254/636867/dc22s017.pdf by guest on 10 July 2022
